Be Clinical Secures $2.2 Million in Latest Pre-Seed Funding Round

Be Clinical secured $2.2 million in its latest Pre-Seed, adding another data point to the Industrials & Manufacturing funding market.

Be Clinical Raises $2.2 million in Funding

$2.2M in Seed Extension Funding USA Be Clinical Raises Approx. Founded by Hemangi Dhir and launched in 2025, Be Clinical develops an aging-focused D2C skincare and medical-grade personal care line built on clinically proven, dermatologically active chemical ingredients.

Investors Behind the Funding

The round was backed by Sauce. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Be Clinical operates in Industrials & Manufacturing. Be Clinical's financing adds to recent private-market activity.

Strategic Use of Funds

Maintain control over product quality and scientific transparency.

Looking Ahead

full-stack model with in-house R&D, manufacturing, and clinically tested formulations

Source reference: original announcement/article.